Altria reported a solid performance in the first half of 2023 despite lower net revenues, partially offset by higher revenue in the oral tobacco segment.

In September the company plans to begin an international test of its new On! Plus tobacco-derived nicotine wet pouch product, which will be available via e-commerce in Sweden. Altria said it is on track to file a premarket tobacco product application (PMTA) with the US Food and Drug Administration (FDA) for On! Plus next year.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us